A recently completed study indicates that circulatory protein levels can provide important information for increasingly accurate diagnoses and personalized care in patients with aggressive B-cell lymphoma. Researchers at the University of Helsinki identified a specific protein profile linked to more severe disease.
This article was originally published on MedicalXpress.com